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ABSTRACT
The Picornaviridae is a large family of positive-sense RNA viruses that contains numerous human and animal pathogens, includ-
ing foot-and-mouth disease virus (FMDV). The picornavirus replication complex comprises a coordinated network of protein-
protein and protein-RNA interactions involving multiple viral and host-cellular factors. Many of the proteins within the com-
plex possess multiple roles in viral RNA replication, some of which can be provided in trans (i.e., via expression from a separate
RNAmolecule), while others are required in cis (i.e., expressed from the template RNAmolecule). In vitro studies have suggested
that multiple copies of the RNA-dependent RNA polymerase (RdRp) 3D are involved in the viral replication complex. However,
it is not clear whether all these molecules are catalytically active or what other function(s) they provide. In this study, we aimed
to distinguish between catalytically active 3Dmolecules and those that build a replication complex. We report a novel nonenzy-
matic cis-acting function of 3D that is essential for viral-genome replication. Using an FMDV replicon in complementation ex-
periments, our data demonstrate that this cis-acting role of 3D is distinct from the catalytic activity, which is predominantly
trans acting. Immunofluorescence studies suggest that both cis- and trans-acting 3Dmolecules localize to the same cellular com-
partment. However, our genetic and structural data suggest that 3D interacts in ciswith RNA stem-loops that are essential for
viral RNA replication. This study identifies a previously undescribed aspect of picornavirus replication complex structure-func-
tion and an important methodology for probing such interactions further.
IMPORTANCE
Foot-and-mouth disease virus (FMDV) is an important animal pathogen responsible for foot-and-mouth disease. The disease is
endemic in many parts of the world with outbreaks within livestock resulting in major economic losses. Propagation of the viral
genome occurs within replication complexes, and understanding this process can facilitate the development of novel therapeutic
strategies. Many of the nonstructural proteins involved in replication possess multiple functions in the viral life cycle, some of
which can be supplied to the replication complex from a separate genome (i.e., in trans) while others must originate from the
template (i.e., in cis). Here, we present an analysis of cis and trans activities of the RNA-dependent RNA polymerase 3D.We dem-
onstrate a novel cis-acting role of 3D in replication. Our data suggest that this role is distinct from its enzymatic functions
and requires interaction with the viral genome. Our data further the understanding of genome replication of this impor-
tant pathogen.
The Picornaviridae family of small, single-stranded positive-sense RNA viruses contains approximately 30 genera and in-
cludes many important human and animal pathogens. Poliovirus
(PV) is the prototype of the enterovirus genus, which also includes
the coxsackieviruses and the rhinoviruses. Other well-studied
genera are the cardioviruses and the aphthoviruses, such as foot-
and-mouth disease virus (FMDV). FMDV is the causative agent of
foot-and-mouth disease, a highly infectious disease of cloven-
hooved animals. Infection presents as an acute systemic disease
with lesions on the feet and mouth; however, under certain cir-
cumstances the virus can adopt an asymptomatic carrier state. The
virus is endemic inmany regions of theworld and can causemajor
outbreaks in domestic livestock with significant economic losses.
Although vaccines are available, disease control is often compli-
cated by high antigenic variability, transmissibility, and infectivity
combined with the problem of asymptomatic carrier animals.
The FMDVRNA genome contains a single open reading frame
flanked by both 5= and 3= untranslated regions (UTRs) (1). The
FMDV 5=UTR contains at least five discrete elements, including a
type II internal ribosome entry site (IRES) (2–4) and the “cis-
acting replicative element” or CRE (5). Additional elements of
unknown function include a large 5= stem-loop termed the S frag-
ment, a polypyrimidine tract of variable length, and various num-
bers of RNA pseudoknots (1, 5–8). The smaller 3= UTR contains
two RNA stem-loops upstream of a 3= poly(A) tail, both of which
have been shown to have roles in viral RNA replication (9, 10).
Translation of the genome yields a single polyprotein which is
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co- and posttranslationally proteolytically processed to produce
the structural and nonstructural (NS) proteins. Initial processing
of the polyprotein generates four primary products: Lpro and the
P1-2A, 2BC, and P3 precursors. Lpro is self-proteolytically pro-
cessed at its C-terminal boundary with P1 (11). Release of P1-2A
from the remaining polyprotein occurs cotranslationally through
a 2A-mediated ribosome-skipping mechanism (12–16). Subse-
quent 3C/3CD-mediated proteolysis of P1-2A generates three
structural proteins, 1AB, 1C, and 1D. 1AB is cleaved via an un-
known mechanism into fully mature 1A and 1B during virion
maturation (17–19). Intermediate polyprotein precursors (2BC
and P3) undergo 3C/3CD-mediated proteolysis to produce the
mature viral RNA replication proteins (20). Final processing of P3
is thought to occur through bothmajor andminor pathways via a
differential set of intermediary precursors to ultimately produce
the 3A transmembrane protein (21–23), three nonidentical tan-
dem copies of the primer polypeptide 3B (3B1–3) (24–28), the
major viral protease 3C (29, 30), and the RNA-dependent RNA
polymerase (RdRp) 3D (also known as 3Dpol) (31). Due to the
limited coding capacity of small RNA viruses, several keyNS poly-
protein precursors perform distinct functions in the viral life cy-
cle. These include the relatively stable precursor proteins 3AB1–3
(3AB in PV) and 3CD (32–34). In addition, many viral proteins
have multifunctional roles in viral RNA replication, some of
which can be supplied in trans (i.e., from a separate RNA mole-
cule), while others are required in cis (i.e., from within the same
RNA molecule) (35–40).
Viral RNA replication is thought to occur within membrane-
associated replication factories known as replication complexes,
where the mature NS proteins together with some precursor pro-
teins are thought to localize. Several RNA elements are also known
to be essential for viral RNA replication, such as the CRE. In
FMDV, this is located within the 5= UTR, whereas in other picor-
naviruses this element can be found within the polyprotein-cod-
ing sequence (5, 41, 42). Both intracellular and in vitro studies
using FMDV or PV have elucidated some of the interactions
within the replication complex. The crystal structures of 3D alone
and in complex, e.g., with RNA and the primer peptide 3B (also
known as VPg) have shed light on themechanism of RNA polym-
erization (31, 43–48). VPg undergoes 3D-mediated uridylylation
on the third tyrosine residue to form VPg-pUpU, which subse-
quently acts as the primer for both positive- and negative-strand
RNA synthesis (49, 50). The template for VPg uridylylation is the
CRE RNA stem-loop (5, 51). However, there is conflicting evi-
dence with PV as to whether the substrate for 3D-mediated VPg
uridylylation is the precursor protein 3AB, 3BC, or 3BCD (52, 53).
Under certain circumstances, the CRE and 3D can be supplied in
trans, suggesting that the uridylylation mechanism is not entirely
cis dependent (36, 39, 40, 54–57). In contrast to 3D, the essential
3CD precursor of PV has no polymerase activity but performs
an independent function in viral RNA replication, most likely
involving interaction with a structured RNA element in the 5=
UTR known as the cloverleaf (58–65). In aphthoviruses, such
as FMDV, the cloverleaf RNA element is replaced by an alter-
native RNA stem-loop structure, the S fragment, located at the
same genomic position and hypothesized to provide the same
function (8, 66, 67).
Assembly of the replication complex is a dynamic process that
is not fully characterized. The current models are thought to re-
quire genomic circularization mediated by a ribonucleoprotein
complex formed between the 5= and 3= UTRs and requiring both
viral and host proteins (37, 58, 59, 65, 68–73). In PV, this likely
involves at least 3CD and poly(rC)-binding proteins 1 and 2
(PCBP1 and -2) at the 5=UTR, binding to the cloverleaf and IRES,
together with poly(A)-binding protein (PABP) at the 3= UTR. In
FMDV, there is evidence that PCBP2 binds the IRES, forming a
complex with proteins at the 3= UTR, e.g., PABP. A recent bio-
chemical study with PV has provided in vitro evidence to suggest
that 3D cannot assemble into the replication complex alone but is
initially assembled as part of a larger precursor, which is subse-
quently processed to the active 3D component (74). Furthermore,
the data from this study also suggest subsequent recruitment of
additional P3molecules (or a smaller precursor thereof) to supply
active 3D and/or VPg to the replication complex. However, it is
not entirely clear whether the samemolecule of P3 provides func-
tional molecules of both 3D and VPg. These observations support
previous studies implicating the involvement of multiple mole-
cules of 3D/3CD in viral RNA replication (75–79) and the obser-
vation that P3 was required to recover replication-defective mu-
tations in 3A and a VPg linkage mutant (57, 80). However, it is
essential to determine whether interactions deduced from in vitro
cell-free studies truly reflect viral RNA replication within the cell.
In this study, we have investigated differential functions of 3D
in the context of FMDV subgenomic replicons.We have exploited
random mutagenesis to identify replication-defective 3D point
mutations in specific functional regions of the polymerase and
introduced these into replicons encoding different reporters for
use in complementation experiments. Although all of the muta-
tions allowed complete P3 processing, only those blocking 3D
catalytic activity were recovered in trans using replication-compe-
tent “helper” transcripts. In contrast, all 3Dmutations to catalytic
and noncatalytic residues were recovered by transcripts that were
replication deficient due to mutations in essential RNA elements.
This implies a separate RNA binding cis-acting role of 3D in viral
RNA replication. X-ray crystallographic studies showed that the
cis-acting mutations did not disrupt the structure of 3D but sug-
gested that they reduced RNA binding affinity. Finally, we suggest
a model for how the different cis and trans actions of 3D contrib-
ute toward replication complex assembly.
MATERIALS AND METHODS
Cell lines. BHK-21 cells obtained from the ATCC (LGC Standard) were
maintained in Dulbecco’s modified Eagle’s medium with glutamine (Sig-
ma-Aldrich) supplemented with 10% fetal calf serum (FCS), 50 U/ml
penicillin, and 50 g/ml streptomycin as previously described (56).
BSR-T7 cells (a kind gift from John Barr, University of Leeds) were main-
tained in Dulbecco’s modified Eagle medium with glutamine (Sigma-
Aldrich) supplemented with 10% FCS, 50 U/ml penicillin, 50 g/ml
streptomycin, and 500 g/ml G418 (Life Technologies).
Plasmid construction. The FMDV replicon plasmids pRep-ptGFP
(where GFP is green fluorescent protein) and pRep-mCherry along with
the equivalent polymerase knockout controls 3D-GNNhave already been
described (56). To introduce individual replication-defective 3D inser-
tions, the corresponding EcoRI-BamHI fragments were removed from
previously reported pGFP-PAC replicons harboring the corresponding
insertions and introduced into EcoRI-BamHI-digested pRep-mCherry.
Individual 3D coding changes were introduced by standard overlapping
PCR mutagenesis using pRep-mCherry as a template with matched for-
ward and reverse mutagenic 3D PCR primers in combination with flank-
ing PCR primers FMDV_4728_45 and FMDV_7200_7180. The second-
round PCR product, generated using the products of the first-round
PCR in combination with PCR primers FMDV_4728_45 
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FMDV_7200_7180, was digested with EcoRI and BamHI and used to
replace the equivalent EcoRI-BamHI fragment from pRep-mCherry. The
same strategy was used to scramble regions in the 3D coding sequence,
using mutagenic PCR primer pairs FMDV_3D_214-221_scrbl_fwd 
FMDV_3D_214-221_scrbl_rvs and FMDV_3D_239-246_scrbl_fwd 
FMDV_3D_239-246_scrbl_rvs.
Deletion of the S fragment was performed by two-step overlapping
PCR mutagenesis with first-round reactions using primer pairs FMDV_
Sfrag5=Eagl_rvs  FMDV_JW1_fwd and FMDV_Sfrag5=EagI_fwd 
FMDV_Sfrag_3=Eagl_rvs.Products fromthefirst roundwereused in second-
round PCR with primers FMDV_JW1_fwd FMDV_Sfrag3=EagI_rvs, and
the PCR product was digested with NheI  SspI and cloned into NheI 
SspI-digested pRep-mCherry to generate pRep-mCherry-Eagl. The S frag-
ment was subsequently removed by digestion of pRep-mCherry-EagI with
EagI before religation to generate pRep-mCherry-S.
To introduce the previously published replication-defective CRE
point mutation (5) into pRep-mCherry, PCR was used with primers
FMDV_CRE_A1G_fwd FMDV_1331-1311, and the PCR product was
digested with AatII and KpnI and ligated into AatII  KpnI-digested
pRep-mCherry to generate pRep-mCherry-CREA1G.
Introduction of C-terminal 3D FLAG and hemagglutinin (HA)
epitope tags first required introduction of a unique BspEI restriction en-
zyme site within the 3= UTR to generate pRep-ptGFP-BseEI. This con-
struct was subsequently used as the template in a two-step PCR, the first-
round reactions involving primer pairs 3D_FLAG_fwd or 3D_HA_fwd
with FMDV_BspEI_7643_21_rvs and 3D_FLAG_rvs or 3D_HA_rvs with
FMDV_6299_6319. The second-round PCR product, generated using the
two first-round PCR products with flanking primer pair FMDV_6299
FMDV_BspEI_7643_21_rvs, was digested with BamHI BspEI and used
to replace the equivalent BamHI  BspEI fragment from pRep-ptGFP-
BseEI, to generate pRep-ptGFP-3DHA and pRep-ptGFP-3DFLAG. Inser-
tion of 3D point mutations was performed using the strategy described
above. To replace the ptGFP reporter gene for Renilla luciferase, the Re-
nilla luciferase reporter gene was amplified by PCR using primers Ren-
Luc_NdeI_fwd and RenLuc_XmaI_rvs and used to replace the ptGFP
reporter gene by NdeI  XmaI restriction enzyme digest. Primer se-
quences are available on request.
In vitro transcription. In vitro transcription reactions were per-
formed as described previously (56). Briefly, 5g of replicon plasmid was
linearized with AscI (NEB), purified by phenol-chloroform extraction,
ethanol precipitated, redissolved in RNase-free water, and used in a 25-l
T7 in vitro transcription reaction mixture. Reaction mixtures were incu-
bated at 32°C for 4 h and treated with 1.25 units of RQ1DNase for 30min
at 37°C, and RNA was recovered using a RNA Clean & Concentrator-25
spin column kit (Zymo Research), in accordance with themanufacturer’s
instructions. All transcripts were quantified by NanoDrop 1000 (Thermo
Scientific), and RNA integrity was assessed by morpholinepropanesulfo-
nic acid (MOPS)-formaldehyde gel electrophoresis before transfection.
Replication and complementation assays. BHK-21-based replicon
replication assays were performed in 24-well plates with 0.5 g/cm2 of
RNA using Lipofectin transfection reagent (Life Technologies) as previ-
ously described (56). For complementation assays, BHK-21 cells seeded
into 24-well plates were allowed to adhere for 16 h before simultaneous
cotransfection with 0.5 g of both ptGFP and mCherry replicon RNAs
using Lipofectin (Life Technologies) according to the manufacturer’s in-
structions. For every experiment, each transfection was performed in du-
plicate, and experiments were subsequently biologically repeated as indi-
cated. Replicon replication was assessed by live-cell imaging using an
IncuCyte Zoom Dual color FLR, an automated phase-contrast and fluo-
rescence microscope within a humidifying incubator. At hourly intervals
up to 24 h posttransfection, 9 images of each well were taken and used to
enumerate the ptGFP/mCherry-positive cells per well and total ptGFP/
mCherry fluorescence intensity per well, using the integrated software.
For each experiment, the data were plotted as both positive cell counts per
well and total fluorescent intensity. No difference was observed when the
data were analyzed as either total cell counts or total fluorescent intensity.
Unless otherwise stated, the data shown here represent fluorescence-pos-
itive cell counts per well.
For DNA transfection of BSR-T7 cells, 6.25  104 cells/cm2 seeded
into 12-well plates were allowed to adhere for 16 h before transfection
with 0.5 g/cm2 of replicon plasmid DNA using Lipofectin reagent (Life
Technologies) according to the manufacturer’s instructions.
Isolation of recombinant genomes. Following cotransfection of
BHK-21 cells with mCherry and ptGFP in vitro-transcribed replicon
RNA, cells were detached by trypsin and washed once in ice-cold phos-
phate-buffered saline (PBS), and total RNA was extracted using the
RNeasy Plus RNA extraction kit (Qiagen) according to the manufactur-
er’s protocol. Total RNA was treated on-column with RQ1-DNase, and
total FMDV cDNAwas amplified using Superscript II (Life Technologies)
according to the manufacturer’s protocol. Both mCherry and ptGFP rep-
licon genomes were amplified separately using forward primers specific
for either mCherry (mCherry_fwd) or ptGFP (ptGFP_fwd) with FMDV-
specific reverse primer (FMDV_7200_7180) with Phusion High-Fidelity
DNA polymerase (NEB). PCR products were blunt-end ligated into
pCRBlunt. Individual colonies were isolated, and the presence of inser-
tional mutation was determined by DNA sequencing.
Western blotting. Immunoblotting was performed as described pre-
viously (81) with primary antibodies rabbit anti-3D 397 polyclonal,
mouse anti-3A 2C2monoclonal, and mouse anti-3B 1F8 monoclonal (all
generous gifts from Francisco Sobrino, Centro De Biologia Molecular
Severo Ochoa, Madrid, Spain), and detection was done with anti-rabbit-
horseradish peroxidase (HRP) (Sigma-Aldrich) or anti-mouse-HRP (Sig-
ma-Aldrich) secondary antibodies, as appropriate. A mouse anti-glycer-
aldehyde-3-phosphate dehydrogenase (anti-GAPDH; Sigma-Aldrich)
primary antibody was used as a loading control.
Immunofluorescence.BHK-21 cells seeded onto glass coverslips were
cotransfected with in vitro-produced transcripts, fixed at the indicated
time in 4% paraformaldehyde, washed in PBS, and permeabilized in sa-
ponin buffer (0.1% saponin, 10% FCS, 0.1% sodium azide) for 1 h at 4°C.
Primary antibodies rabbit anti-FLAG (Sigma-Aldrich) and mouse anti-
HA (Sigma-Aldrich) were added in saponin buffer for 2 h at room tem-
perature. Secondary antibodies used for detection were anti-rabbit-Alexa
Fluor 568 and anti-mouse-Alexa Fluor 647 (Life Technologies), as appro-
priate. Coverslips were washed three times in saponin buffer between
antibody steps. Coverslips were washed a final time in PBS before mount-
ing in ProLong Gold with 4=,6-diamidino-2-phenylindole (DAPI; Life
Technologies). Images were captured using a Zeiss LSM-880 inverted
confocal microscope.
Protein purification and crystallization. The GC216/7AA mutation
was introduced into the His-tagged 3D expression clone pET28a-3D (as
described in references 31 and 76), using standardmolecular cloning tech-
niques. Mutant polymerase was expressed and purified as previously de-
scribed (31, 76). A last purification step was required for crystallization; a
size exclusion on a Superdex 200 16/60 (GE Healthcare) with the protein
buffer (500 mM NaCl, 50 mM Tris-HCl [pH 8.0], 8% glycerol, 0.8 mM
dithiothreitol [DTT], and 0.8 mM EDTA). The protein was concentrated
to 5 mg/ml using an Amicon Ultra concentrator (10.000 MWCO PES;
Millipore) previously equilibrated with protein buffer. The protein was
aliquoted, frozen, and stored at 193 K. The purity and homogeneity of the
protein were analyzed by SDS-PAGE. The oligonucleotide 5=-GCAUGG
GCCC (NWG-Biotech) was annealed as described previously (31). 3D
was added slowly to the annealed oligonucleotide in the presence of 2mM
MgCl2, to reach equimolar proportions. Crystallizationwas performed by
the hanging-drop vapor diffusion method at 293 K in a 24-well Greiner
plate. One microliter of protein solution was mixed with 1 l of precipi-
tant solution; the volume reservoir was 1ml. The best crystals appeared in
2 or 3 days from a solution containing 30% polyethylene glycol (PEG)
4000, 0.2 M magnesium acetate, 0.1 M MES (morpholineethanesulfonic
acid [pH 6.0]), and 4% -butyrolactone.
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X-ray diffraction analysis. The 3D-GC216/7AA data sets were col-
lected at the Alba-Cells synchrotron light facility (Barcelona) on a Pilatus
6MDectris detector at beamline Xaloc using a wavelength () of 0.979 Å.
All the data sets were recorded at 100 K. Crystals diffracted to 2.8-Å reso-
lution (Table 1). Four hundred images were collected with an oscillation
angle of 0.25° and 0.66 s of exposure time. Diffraction images were pro-
cessed with XDS (82, 83) and internally scaled with SCALA (CCP4i [84])
(Table 1).
Structure solution and refinement. The initial maps were obtained
after rigid-body fitting of the coordinates of the wild-type 3D, crystallized
in the trigonal space group P3221 (PDB 1WNE [31]), after removing the
bound RNA using the program Refmac5 (CCP4i [85]) (Table 1). The
difference density maps were clear enough to allow retracing of the mu-
tated residues and the RNA template-primer decanucleotide bound to the
polymerase central cavity. Several cycles of automatic refinement, per-
formed with Refmac5 (CCP4i [85]) and Phenix software (86) were alter-
nated with manual model rebuilding using Coot (87, 88). The refinement
statistics are summarized in Table 1.
Protein structure accession number. The crystallographic coordi-
nates determined in this study have been deposited in the Protein Data
Bank, with accession number 5JXS.
RESULTS
Replication-defective 3D insertional mutations can be recov-
ered by cotransfectionwith awild-type replicon.Due to the lim-
ited coding capacity of positive-strand RNA viruses, many viral
proteins have multifunctional roles in RNA replication. Several
studies have demonstrated that the replication of picornaviruses
containing replication-defective mutations in some NS proteins
can be recovered by expressing the corresponding wild-type pro-
tein in trans (i.e., from a separate RNAmolecule) (35–40). This is
in contrast to certain NS protein functions that are seemingly
required in cis (i.e., expressed from the same molecule). In this
study, we set out to investigate such differential functions of
FMDV 3D.
We recently reported the use of replication-defective trans-
poson-mediated insertional mutagenesis to reveal replication-de-
fective mutations across the FMDV NS polyprotein (56). In the
same report, we demonstrated that replication-defective inser-
tions in the 3A NS protein could be recovered in trans by cotrans-
fection with wild-type “helper” replicons in a complementation
assay using replicons with different reporters. We also observed
that a replication-defective point mutation in motif C of 3D (3D-
GNN) could be recovered using a wild-type helper replicon (Fig.
1). We had also identified nine separate replication-defective in-
sertion mutations within 3D (as summarized in Table 2) and
therefore first sought to investigate whether such replication-de-
fective 3D insertion mutations could be recovered by cotransfec-
tion with helper replicons in complementation experiments. To
this end, the nine replication-defective 3D insertion mutations
(3DTn-I102 to 3DTn-S250, the name being derived from the
amino acid position after which transposon insertion occurred
[56]) were introduced into an FMDV replicon in which the
structural proteins had been substituted for the reporter pro-
tein mCherry (as described in reference 56), thus allowing rep-
lication to be monitored via fluorescent transgene expression
(81, 89) (Fig. 2A).
As expected, all nine 3D insertionswere replication defective in
the context of the mCherry reporter replicon, with mCherry ex-
pression approximately equivalent to the replication-defective
control construct 3D-GNN (Fig. 2B). After confirming that all
nine 3D insertions were replication defective, the ability of these
constructs to be recovered was screened by cotransfection with a
wild-type helper replicon expressing ptGFP in place of mCherry
(as described in reference 56) or yeast tRNA as a negative control
for input translation. The use of two different fluorescent report-
ers allowed for discrimination of replication between the mutant
and helper replicons. Alongside, the wild-type mCherry replicon
and the mCherry replicon bearing the point mutation to the 3D
motif C active site (3D-GNN) (90, 91) were also cotransfected
with helper replicon or yeast tRNA. Reporter gene expression was
monitored over a 24-h period with an IncuCyte Zoom FLR (as
described in Materials and Methods), with data presented at 8 h
posttransfection, when reporter gene expression was maximal
(Fig. 2B and C).
As described above, the replicon containing the motif C 3D-
GNN active-site mutation could be recovered by cotransfection
with a wild-type helper replicon (Fig. 2B). With the wild-type
mCherry replicon, there was no significant difference in mCherry
expression when cotransfected with yeast tRNA control or the
wild-type helper replicon, as expected. Four of the replicons bear-
ing replication-defective 3D insertion mutations (3DTn-L163,
3DTn-A175, 3DTn-D240, 3DTn-A246) were recovered by cotrans-
fection with helper replicon, all demonstrating at least a 5-fold,
significant increase in replication compared to the yeast tRNA
TABLE 1 Refinement statistics
Collection and refinement Value(s)c
Datum collected
Resolution (Å) 47.95–2.8 (2.95–2.8)
Space group P3221
Cell dimensions
a, b, c (Å) 95.78, 95.78, 100.88
, 	, 
 (°) 90, 90, 120
Rmerge (%) 8.3 (76.8)
I/I
Completeness (%) 95.3 (93.7)
Multiplicity 2.2 (2.0)
Refinement
Resolution (Å) 47.95–2.8
No. of reflections (total/unique) 28,367/12,908
Rworka/Rfreeb 21.63/28.44
No. of atoms/residues
Protein 476
Ligand 14 RNA
Water 9H2O/1Mg
2
B factors (Å2)
Overall 24.002
Protein 23.316
RNA 31.785
Water ligands 46.102
Rmsd
Bond lengths (Å) 0.0079
Bond angles (°) 1.2165
Ramachandran plot
Residues in preferred regions 459/0476 (96.8%)
Residues in allowed regions 14/476 (3%)
a Rwork hkl ||Fobs(hkl)| |Fcalc(hkl)||/hkl |Fobs(hkl)|, where Fobs and Fcalc are
the structure factors, deduced from measured intensities and calculated from the
model, respectively.
b Rfree is calculated as for Rwork but for 5% of the total reflections chosen at random
and omitted from refinement.
c Values in parentheses correspond to the highest-resolution shell (PDB accession
number 5JXS).
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FIG 1 Cartoon of the FMDV replicons used in complementation assays. Schematics of the FMDV subgenomic replicons used in this study. Complementation
experiments involved simultaneous cotransfection of BHK-21 cells with equal amounts of replication-defective “mutant” RNA with helper replicon or yeast
tRNAas a negative control. Replication ofmutant and helper constructs was subsequentlymonitored by differential expression of fluorescent reporter transgenes
encoding ptGFP and mCherry. Expression of ptGFP (A and B) and mCherry (C and D) was monitored hourly over a 24-h period. (A and C) Data are typically
represented as mean positive cells per well standard deviations (SD) at 8 h posttransfection. (B and D) Time course of fluorescence expression over 20 h from
a subset of samples (n 3). The point mutation to the 3D active-site motif C (3D-GNN) has previously been shown to be recovered in trans by cotransfection
with wild-type replicon.
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negative control (Fig. 2B). No significant increase in mCherry
expression was observed with the remaining five replication-de-
fective replicons containing insertion mutations 3DTn-I102,
3DTn-C217, 3DTn-P219, 3DTn-C249, and 3DTn-S250. There
was no significant difference in wild-type ptGFP helper replicon
replication when cotransfected with any of themCherry replicons
(Fig. 2C).
The published crystal structures of 3D alone and in complex
TABLE 2 Locations of replication-defective 3D insertionsa
Name Nucleotide insertion site Nucleotide insertion Amino acid sequence
3DTn-I102 306 CAAGTGCGGCCGCATCA IYEAIKCGRIKGVDG
3DTn-L163 489 GAATGCGGCCGCACTGA CQTFLNAAALKDEIR
3DTn-A175 525 GGTGCGGCCGCAGCCGG EKVRAGAAAAGKTRI
3DTn-C217 651 CAACTGCGGCCGCAGCA SAVGCNCGRSNPDVD
3DTn-P219 657 CTGATTGCGGCCGCACT VGCNPDCGRTDVDWQ
3DTn-D240 716 ATGCGGCCGCAGTGGAC VWDVDAAAVDYSAFD
3DTn-A246 738 TAATGCGGCCGCAGCTA SAFDANAAAANHCSD
3DTn-C249 747 TAGTTGCGGCCGCAGTA DANHCSCGRSSDAMN
3DTn-S250 750 GTTGCGGCCGCAGTAGT ANHCSCGRSSDAMNI
a The nucleotide or amino acid after which insertion occurred is shown in bold. The inserted sequence is underlined.
FIG 2 Replication-defective 3D insertions can be recovered using wild-type helper replicon. (A) Cartoon of the FMDV replicon, including a schematic of the 3D
sequence with conserved functional regions highlighted. The seven conserved motifs are colored as follows: A, red; B, green; C, yellow; D, light blue; E, orange;
and F, dark blue. The region shown to interact with dsRNA is shaded in black. Complementation experiments involved cotransfecting mCherry replicons
containing replication-defective 3D insertions, indicated with arrows, with wild-type ptGFP helper replicons or yeast tRNA. BHK-21 cells were seeded into
24-well plates and allowed to adhere for 16 h. Cells were cotransfected with mCherry replicons bearing replication-defective 3D insertions, a motif C active-site
3D mutation (3D-GNN), or a wild-type (wt) mCherry replicon control, together with wild-type ptGFP helper replicon or yeast tRNA as a negative control.
Expression of mCherry (B) and ptGFP (C) was monitored hourly over a 24-h period. Data are represented as mean positive cells per well  SD at 8 h
posttransfection. Significance between plus ptGFP and plus yeast tRNA control (n 3): *, P 0.05; **, P 0.01; ***, P 0.001.
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with RNA (31, 43–46, 92) allowed the locations of the replication-
defective insertions to be identified structurally. Insertion muta-
tions 3DTn-L163 and 3DTn-A175 were within the finger domain
motif F, involved in interacting with the entry of incoming rNTPs.
The two remaining recoverable insertion mutations, 3DTn-D240
and 3DTn-A246, were within the palm motif A, proximal to two
catalytic aspartic acid residues (D240 and D245) responsible for
nucleotide selection and binding and involved in stabilizing the
interaction with the catalytic metal ions.
The five nonrecoverable insertion mutations also located to
two distinct sites. Insertion mutations 3DTn-C217 and 3DTn-
P219 were localized within the loop region, which, based on the
crystal structure of 3D in complex with RNA, is hypothesized to
directly participate in the protein-RNA contacts in the double-
stranded RNA (dsRNA) exit site. Insertionmutations 3DTn-I102,
3DTn-C249, and 3DTn-S250 were located on the polymerase sur-
face and are predicted to be involved in 3D protein-protein inter-
actions directing the crystal packing in different 3D crystal forms
(31, 43–45).
Recovery of replication-defective 3Dmutations is not solely
through recombination. The presence of small replication-de-
fective insertional mutations in 3D acts as a genetic marker
allowing the replication-defective genomes to be easily distin-
guished from the replication-competent “helper” genomes by
PCR. Cotransfection of replication-defective with replication-
competent genomes might be expected to give rise to replicative
recombinants through polymerase strand switching.
To investigate whether we could detect recombinants or
wild-type revertants, the mCherry replicons bearing the repli-
cation-defective 3D insertional mutations (3DTn-I102 to
3DTn-S250) were cotransfected with the wild-type ptGFP
helper construct, the ptGFP-3D-GNN construct, or yeast tRNA
controls and RNA extracted at 8 h posttransfection. Both
mCherry and ptGFP replicon genomes were amplified sepa-
rately by reverse transcription-PCR using forward primers spe-
cific for mCherry or ptGFP, as appropriate. As anticipated, an
mCherry-specific band of the expected size could be observed
only when the 3DTn-L163, 3DTn-3DTn-A175, 3DTn-D240,
and 3DTn-A246 mutant replicons were cotransfected with
wild-type ptGFP helper replicon (data not shown). To isolate
recombinants, this PCR product was subcloned into a plasmid
vector, and the nonstructural region was sequenced from indi-
vidual clones.
A total of 20 clones of the 4 recoverable 3D insertions (3DTn-
L163, 3DTn-3DTn-A175, 3DTn-D240, and 3DTn-A246) were se-
quenced. The insertional mutation was clearly identifiable in 14
clones, with 6 clones having lost the insertional mutation, thus
having a wild-type sequence (data not shown). No other point
mutations were identified across the sequenced region. These data
would suggest that the majority of genomes are not recombinants
and that the recovery observed is not solely through the effect of
recombination. However, recombinant genomes were clearly de-
tected, presumably as a result of polymerase strand switching
within mixed replication complexes.
Pointmutations within 3D catalyticmotifs can be recovered
by cotransfection with wild-type replicon. The results above
showed that approximately one-half of the replication-defective
3D insertions could be recovered by cotransfection with a wild-
type helper replicon. The other half were nonrecoverable with a
wild-type construct, suggesting differential trans (i.e., recoverable
with helper replicon) and cis (i.e., not recoverable) functions of
3D. However, all of these mutations represent 5 amino acid inser-
tions, which could cause a general disruption to protein folding
and stability, as opposed to point mutations designed to abrogate
a specific protein function (such as a GNN active-site point mu-
tation).We therefore sought to replicate the phenotypes observed
above with the replication-defective 3D insertions with site-di-
rected point mutations. For this, we chose one location that was
recovered and one that was nonrecoverable; these were the repli-
cation-defective mutations in motif A and the dsRNA exit site,
respectively.
Replication-defective insertions within motif A, characterized
by insertional mutations 3DTn-D240 and 3DTn-A246, were lo-
cated adjacent to either of the catalytic aspartic acid residues D240
andD245, shown in crystal structures to interact with the catalytic
metal ion. We therefore hypothesized that these insertions abro-
gated the function of these aspartic acid residues, and to investi-
gate this, we generated three new ptGFP replicon constructs bear-
ing either a D240N or D245N point mutation or a DD240/5NN
double point mutation. The two replication-defective nucleotide
insertion mutations located in the dsRNA exit site, 3DTn-C217
and 3DTn-P219,were situated in close proximity to residuesG216
and P219, which are thought to interact with RNA in the dsRNA
exit site (31). However, it was difficult to infer from the crystal
structures which of these residues are critical to 3D function.
Therefore, to identify replication-defective point mutations in
this region, we undertook alanine scanning mutagenesis across
the residues G216 to P219, to generate three new ptGFP replicon
constructs containing either a 3D-GC216/7AAor 3D-NP218/9AA
double point mutation or a 3D-GCNP216-219AAAA quadruple
mutation (Fig. 3A).
The ability of these six new ptGFP constructs to replicate was
assessed in BHK-21 cells along with a wild-type positive control
and polymerase active-site 3D-GNN mutation negative control
(Fig. 3B). As expected, both 3D-D240N and 3D-D245N muta-
tions and the combined 3D-DD240/5NNdoublemutation within
motif A completely prevented replication (Fig. 3B). Likewise, the
dsRNA exit site mutations 3D-GCNP216-9AAAA and 3D-
FIG 3 Replication-defective mutations in 3D motifs A and C can be recovered using wild-type helper replicon. (A) Cartoon of the FMDV replicon bearing
replication-defective polymerase pointmutations and a simplified version of themCherry helper replicon (see Fig. 1 for full schematic). The schematic of the 3D
polymerase gene is shown with the conserved motifs A to F highlighted. Arrows indicate the locations of mutated residues. Complementation assays involved
cotransfection of ptGFP replicons bearing 3D point mutations with wild-type mCherry helper replicon or yeast tRNA. BHK-21 cells seeded into 24-well plates
were cotransfected with ptGFP replicons harboring replication-defective 3D point mutations or a wild-type control, together with wild-type mCherry helper
replicon or yeast tRNA as a negative control. Expression of ptGFP (B andD) andmCherry (C and E) weremonitored hourly over a 24-h period. Data showmean
positive cells per well SD (B andC) ormean total fluorescent intensity per well SD (D and E) at 8 h posttransfection. Significance between plusmCherry and
plus yeast tRNA control (n 2): *, P 0.05; **, P 0.01; ***, P 0.001. (F) Diagrammatic representation of the 3D crystal structure showing the position of
recoverable and nonrecoverable replication-defective point mutations as light green and hot pink spheres, respectively. Motif C containing the active-site GDD
motif is colored yellow. Motifs A and F are colored red and dark blue, respectively.
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GC216/7AA were both replication defective, with ptGFP expres-
sion equivalent to the 3D-GNN motif C knockout control (Fig.
3B). In contrast, the 3D-NP218/9AA mutation in the dsRNA exit
site demonstrated robust replication, with only a 2- to 3-fold de-
crease in ptGFP expression compared to the wild-type construct
(Fig. 3B). From this we concluded that disruption of residues
G216 and C217 was responsible for the replication-defective phe-
notype in the dsRNA exit site.
Next, we determinedwhether these replication-defective point
mutations in 3Dmotif A or the dsRNA exit site could be recovered
in a complementation assay (as described in the legend to Fig. 3A).
For pragmatic reasons from this point on, all complementation
assays were performed with mutant ptGFP replicon and helper
replicons expressing mCherry. Therefore, the ptGFP replicons
bearingmutations 3D-D240N, 3D-D245N, 3D-DD240/5NN, 3D-
GC216/7AA, 3D-NP218/9AA, or 3D-GCNP216-9AAAA were
cotransfected with the wild-typemCherry helper replicon or yeast
tRNA as a negative control, and replication was monitored by
transgene expression. The wild-type and 3D-GNN ptGFP repli-
cons were also included as controls (Fig. 3B and C).
The three motif A mutations (3D-D240N, 3D-D245N, and
3D-DD240/5NN) were significantly recovered by cotransfection
with a wild-type helper mCherry replicon (Fig. 3B). In contrast,
neither of the dsRNA exit site point mutations (3D-GC216/7AA
or 3D-GCNP216-9AAAA) was recovered, with no significant in-
crease in ptGFP expression when cotransfected with helper con-
struct compared to yeast tRNA control (Fig. 3B). There was no
significant difference in ptGFP expression with the 3D-NP218/
9AA construct when cotransfected with a helper construct com-
pared to the yeast tRNA negative control. Again, there was no
significant difference in replication of the helper construct when
cotransfected with the wild-type or any of the replication-defec-
tive 3D replicons, compared to the yeast tRNA control (Fig. 3C),
suggesting no dominant negative effects on replicationwith any of
the 3Dmutations. The same results were observedwhen analyzing
expression as either total ptGFP and mCherry fluorescent inten-
sity or as total fluorescent cell counts per well; for completeness,
this is shown in Fig. 3D and E. Thus, the results with 3D point
mutations correspond to those observed above with replication-
defective 3D insertion mutations (Fig. 2), with motif A mutations
significantly recovered while dsRNA exit site mutations were un-
recoverable (Fig. 3F). Such observations implicate different trans
and cis functions of 3D that are essential for viral replication.
Replication-defective 3D point mutations do not change
RNA structure. Previous studies have described RNA structural
elements within the 3D coding region of some picornaviruses,
which are hypothesized to have an essential role in viral RNA
replication (93). It was possible that the mutations introduced
within the 3D motif A (3D-DD240/5NN) or the dsRNA exit site
(3D-GC216/7AA) inhibited replication by disruption of specific
local RNA sequence, as opposed to disruption of protein function.
To investigate this possibility, the 3D codon usage spanning the 8
residues comprising the whole ofmotif A (residues V239 to A246)
or the whole dsRNA exit site (residues A214 to V221) were
changed in the ptGFP replicon to maintain the amino acid se-
quencewhile introducing themaximumnumber of changes to the
nucleotide sequence. These two new “scrambled” replicons, 3D-
214-221Scmbl and 3D-239-246Scmbl, therefore maintained the
amino acid sequence of 3D, but with a different RNA sequence.
The replication of both scrambled replicon constructs was as-
sessed in BHK-21 cells along with wild-type ptGFP positive con-
trol and the motif C polymerase knockout negative control (3D-
GNN) (Fig. 4A). Both replicons with a scrambled nucleotide
sequence across either motif A or the dsRNA exit site replicated in
a fashion similar to that of the wild-type construct. These data
suggest that the replication-defective mutations introduced into
eithermotif A or the dsRNA exit site were due to changes in the 3D
protein sequence and were not a result of local change in the RNA
sequence.
Nocodazole inhibition of complementation. Studies with PV
have indicated that transient cell chilling followed by the addition
of the drug nocodazole blocked complementation by the depoly-
merization of microtubules and prevention of coalescence of rep-
lication complexes (94, 95). To investigate the influence of no-
codazole on FMDV complementation, the ptGFP-3D-GNN
replicon was cotransfected with the wild-type mCherry helper
construct, themCherry-3D-GNN replicon, or yeast tRNA follow-
ing treatment with nocodazole. The wild-type ptGFP replicon
was included as an internal control and recovery of replication
assessed via fluorescent protein expression over time, with data
showing maximal ptGFP expression at 8 h posttransfection
(Fig. 4B).
Contrary to data published for PV, treatment with 5 M no-
codazole resulted in approximately 30% reduction in replicon
replication (data not shown). Despite this reduction, normaliza-
tion of the data revealed that treatment with nocodazole signifi-
cantly inhibited recovery of the 3D-GNN construct by wild-type
helper replicon (Fig. 4B). These data suggest that recovery of rep-
lication-defective 3D mutations involves a process that requires
mixing of replication complexes.
Replication-defective 3D point mutations do not affect P3
processing. Having confirmed that the replication-defective
changes to 3D were a result of protein modification and not local
RNA changes, we sought to identify whether such mutations af-
fected 3D processing or stability. Directly transfecting replicon
DNA into BSR-T7 cells (BHK-21 cells stably expressing T7 poly-
merase) allows for continuous replicon transcription and transla-
tion in the absence of replication, thus allowing for the detection
of nonstructural proteins from replication-defective constructs.
BSR-T7 cells were therefore transfected with replicon construct
DNA containing the 3D motif A and dsRNA exit site mutations
alongwithwild-type and 3D-GNNcontrols.Western blot analysis
revealed no notable difference in 3D precursors between the wild-
type and mutant constructs (Fig. 4C). There was also no notable
difference in 3D expression levels between the wild-type con-
structs and constructs carrying the motif A (3D-D240N, 3D-
D245N, 3D-DD240/5NN) or motif C (3D-GNN) mutations. In
contrast, there was reduced 3D expression from both the dsRNA
exit site mutants (3D-GC216/7AA and 3D-GCNP216-9AAAA),
in particular the quadruple mutant, which showed very little ex-
pression of 3D, suggesting that mutations in this region have det-
rimental effects on protein stability. However, there was a smaller
reduction in 3D expression from the double mutant 3D-GC216/
7AA. For this reasonwe chose this doublemutation, in addition to
the 3D-DD240/5NN double point mutation in motif A and 3D-
GNN mutation in motif C, for further study.
Replication-defective 3D colocalizes with wild-type 3D in
replicon-cotransfected cells. It was anticipated that cotransfec-
tion of mutant and helper replicons would result in colocalization
of both mutant and helper 3D within the same cellular compart-
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ment. Investigation of this required differential labeling of the two
subsets of 3D molecules. For this purpose, 3D was modified to
contain either a C-terminal FLAG or HA epitope tag within the
context of the replicon expressing the ptGFP reporter, allowing
the tagged molecules to be detected by indirect immunofluores-
cence using commercially available antibodies. In vitro-synthe-
sized RNA from these new epitope-labeled constructs was trans-
fected intoBHK-21 cells alongwith appropriatewild-type positive
and polymerase knockout (3D-GNN) negative controls, and pt-
GFP expression was monitored over time (Fig. 5A). Both FLAG-
and HA-labeled ptGFP replicons yielded ptGFP expression indis-
tinguishable from that of the wild-type ptGFP construct (Fig. 5A),
showing that both C-terminal epitope tags were well tolerated and
had no detrimental effect on RNA replication.
To check that the replication-defective polymerase mutations
did not result in protein mistargeting, the C-terminal FLAG tag
was combinedwith the 3D-DD240/5NN, 3D-GC216/7AA, or 3D-
GNN mutations, and RNA was generated and transfected along
with wild-type ptGFP-3D-FLAG control into BHK-21 cells. Cells
were fixed at 4 h posttransfection, labeled for FLAG-tagged 3D,
and analyzed by immunofluorescence (data not shown). There
was no appreciable difference in the cellular distribution of mu-
tant and wild-type polymerases, all of which showed a diffuse
punctate pattern of staining scattered throughout the cytoplasm
(data not shown), albeit with the wild-type replicon displaying
greater 3D expression, as would be expected.
The ability to tag 3D with two alternative epitopes (i.e., FLAG
or HA) allowed us to study the localization of mutant and helper
3D in replicon-cotransfected cells. Helper constructs were gener-
ated in which the mCherry fluorescent reporter was replaced with
Renilla luciferase and the 3Dmodified to contain aC-terminalHA
tag to permit dual-color immunofluorescence analysis. The new
luciferase-expressing helper constructs were cotransfected into
BHK-21 cells along with the ptGFP replicons carrying FLAG-la-
beled polymerase mutations (3D-GNN, 3D-DD240/5NN, 3D-
GC216/7AA) or wild-type control, and cells were fixed at 4 h post-
transfection and costained for FLAG and HA expression (Fig. 5B
andC). In all cases, colocalizationwas clearly detected between the
wild-type HA-labeled andmutant FLAG-labeled polymerases, in-
dicative of mixed replication complexes. These data provide fur-
ther evidence that all the replication-defective mutant 3D poly-
merases can successfully target the presumed site of viral RNA
replication when supplied with a wild-type replicon and that re-
covery of replication occurs through the mixing of replication
proteins.
Removal of 5=-UTR RNA elements from the helper replicon
improves recovery of replication-defective 3Dmutations.There
is evidence to suggest thatNS proteins of FMDV, either alone or as
uncleaved precursor(s), interact with both the CRE and a 5= RNA
structure known as the S fragment (38, 66, 96). We hypothesized
that such structured RNA elements in the helper constructs may
sequester 3D and/or its precursors in cis and so reduce its avail-
ability to recover replication-defective replicons. To test this hy-
pothesis, a new set of replication-defective mCherry constructs
were generated containing either a previously described function-
ally inactivating AG point mutation in the CRE (mCherry-
CREA1G) (5) or a complete deletion of the S fragment (mCherry-
S). Both of these mutations render the replicon replication
defective (data not shown). In addition, two further replicons
were built by combining the replication-defective 3D-GNN mu-
FIG 4 Replication-defective 3Dmutations do not affect RNA structure or 3D
polyprotein processing. (A) Replicon RNAs containing codon-modified 3D
were transfected into BHK-21 cells along with control replicons, and ptGFP
expression was monitored hourly over 24 h. Data show mean numbers SD
of ptGFP-positive cells per well at 8 h posttransfection (n  2). (B) Effect of
nocodazole on complementation. BHK-21 cells treated with 5Mnocodazole
or left untreated (see Materials and Methods for details) were cotransfected
with wild-type or 3D-GNN ptGFP replicon RNA together with helper
mCherry replicon or yeast tRNAnegative control. ptGFP expressionwasmon-
itored for 24 h. Data show normalized numbers of ptGFP-positive cells per
well standard errors of themeans (SEM) at 8 hposttransfection. Significance
between results for untreated samples and samples treated with 5Mnocoda-
zole (n 3) was determined: *, P 0.05. (C)Western blot analysis of replicon
DNA constructs transfected into BSR-T7 cells. Cells were seeded into 12-well
plates, allowed to adhere for 16 h, and transfected with ptGFP replicon DNA
constructs as indicated, and protein was harvested at 12 h posttransfection.
Lysates were analyzed by Western blotting for 3D and GAPDH (glyceralde-
hyde-3-phosphate dehydrogenase) expression.
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FIG 5 Wild-type helper 3D colocalizes with replication-defective mutant 3D. (A) Replicon RNAs containing C-terminal epitope labels were transfected into
BHK-21 cells, and ptGFP expression was monitored hourly over a 24-h period. Data show mean numbers  SD of ptGFP-positive cells per well at 8 h
posttransfection (n  2). (B) BHK-21 cells were cotransfected with FLAG-tagged mutant 3D replicons and HA-tagged 3D helper replicons, fixed at 4 h
posttransfection, and labeled for FLAG-Alexa Fluor 568 (pseudocolored green) and HA-Alexa Fluor 647 (pseudocolored red) as described in Materials and
Methods. Cell nuclei were counterstained with DAPI (blue). Images were captured on a Zeiss LSM-880 confocal microscope with Airyscan. Zoomed images
represent the boxed areas on the merged images (bar, 20 M). (C) Quantification of FLAG versus HA colocalization by confocal immunofluorescence.
Fluorescent intensity of 3D-FLAG (green) versus 3D-HA (red) was plotted as two-dimensional (2D) scatterplots, and the number of costained pixels was
determined by a 4-area gating set using controls. Data points show the percentages of coexpressing pixels from 8 randomly selected cells after cotransfection.
Horizontal lines represents mean values SEM.
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tation with either the CREA1G or S mutations to generate
mCherry-CREA1G-3D-GNN and mCherry-S-3D-GNN, respec-
tively. These four new replicons (with functional or nonfunctional
3D) were assayed for their ability to recover replication of the
3D-DD240/5NN, 3D-GC216/7AA, and 3D-GNN mutant con-
structs, in reciprocal complementation experiments (56) (Fig. 6A
to E).
As observed previously, both 3D-GNN and 3D-DD240/5NN
mutations were significantly recovered by cotransfection with the
wild-type construct. However, recovery was enhanced upon
cotransfection with either replication-defective mCherry-S or
mCherry-CREA1G replicons. Consistent with our earlier results,
there was no significant increase in ptGFP expression when the
3D-GC216/7AA was cotransfected with a wild-type replicon.
However, this mutation showed a 100-fold statistically signifi-
cant increase in ptGFP expression upon cotransfectionwith either
the mCherry-S (Fig. 6B) or mCherry-CREA1G replicons (Fig.
6C). No recovery was observed with either of the constructs car-
rying the replication-defective 3D-GNN mutation, as expected.
As before, there was no significant difference in replication of the
wild-type mCherry construct when cotransfected with any of the
replication-defective 3D replicons. In contrast, the replication of
bothmCherry-S (Fig. 6D) andmCherry-CREA1G replicons (Fig.
6E) was significantly recovered upon cotransfection with any of
the mutant 3D replicons. Furthermore, ptGFP-3D-GNN, ptGFP-
3D-DD240/5NN, and ptGFP-3D-GC216/7AA were each able to
recover mCherry-S and mCherry-CREA1G replication to ap-
proximately equal levels.
Three-dimensional structure of the 3D-GC216/7AA mutant
polymerase. To gather further information on how the GC216/
7AA mutation may alter 3D-RNA interactions, the protein was
produced as a His-tagged fusion in Escherichia coli as previously
described (31, 76) and prepared for crystallization in complex
with a short RNA oligomer.
The X-ray structure of the 3D-GC216/7AA polymerase, in
complex with the RNA template/primer 5=-GCAUGGGCCC, was
solved at 2.8-Å resolution (Table 1 and Fig. 7A). The initial differ-
ence maps allowed unequivocal tracing of the substituted
(GC216/7AA) and surrounding (from V215 to D220) residues
that were omitted from the initial model to eliminate model bias
(Fig. 7A). These maps also indicated the presence of the duplex
portion of the template-primer in the central cavity of the enzyme
and the AU nucleotides, belonging to the template 5= overhang
region, bound to the template channel (Fig. 7A and B).
Structural comparisons showed that the 3D-GC216/7AA mu-
tant polymerase is almost identical to the wild-type 3D. The su-
perimpositions of all 476 amino acid residues of the 3D-GC216/
7AA-RNA complex onto the wild-type 3D-RNA structure (PDB
1WNE) yielded root mean square deviation (rmsd) values of only
0.51 Å. Structural comparisons also showed a subtle movement of
the loop containing the mutated residues GC216/7AA, which was
displaced by0.74 Å toward the RNAprimer (Fig. 7C). However,
this small displacement does not alter the 3D-RNA interactions at
the dsRNA exit site. The main differences lie in the template entry
channel, in particular in the M16-R17 segment, located distal
from themutated region (Fig. 7C). Interestingly, all the structures
of the wild-type FMDV 3D catalytic complexes analyzed to date
show that the basic side chain of R17 is involved in a different
interaction with the template nucleotide at the position t 2 (44,
45, 97). In these complexes, the t 2 nucleotide points toward the
active-site cavity, stacked with the t 1 nucleotide that is located
in the opening of the central cavity (Fig. 7C, bottom right inset). In
contrast, in the GC216/7AA structure, themain and side chains of
residues M16 and R17 appeared reoriented, with the R17 side
chain pointing to the polymerase interior, interacting with resi-
dues N41 and Y285. A similar reorganization of the template
channel entry has been previously shown in other FMDV 3Dmu-
tants presenting alterations in RNAbinding affinity and incoming
nucleotide incorporation (46, 98). This rearrangement results in
the formation of distinct pockets where the t 2 nucleotide binds
(Fig. 7C, top right inset). These structural data would imply an
RNA binding deficiency of this mutant polymerase consistent
with the above-described data.
Expression of 3D alone is not sufficient for recovery of 3D
mutations. Mature 3D is produced via a series of polyprotein
intermediate or precursor proteins. It is generally believed that
these precursors provide additional functionality in genome rep-
lication. To investigate whether it was possible to recover replica-
tion-defective 3Dmutations by expression of 3D alone, RNA con-
structs that express either 3D alone or the entire 2A-3D
polyprotein directly from the FMDV IRES were generated. We
first verified protein expression by transfection of these two ex-
pression constructs into BSR-T7 cells. As controls, BSR-T7 cells
were also transfected with wild-type mCherry and mCherry-S
replicon DNA (Fig. 8A). As expected, expression of 3D could
clearly be detected in all cases.
To assess recovery of the ptGFP-3D-GNN replicon, T7 poly-
merase in vitro RNA transcripts were generated from the 2A-3D
and 3D expression constructs, along with controls, and cotrans-
fected into BHK-21 cells as previously described. Cotransfections
were also performed with the wild-type ptGFP replicon to check
for dominant negative effects (Fig. 8B).
As anticipated, replication of the ptGFP-3D-GNN replicon
was recovered by cotransfection with the wild-type helper repli-
con. This recovery was again improved by cotransfection with the
replication-defective mCherry-S transcript. Expression of the
full-length 2A-3D polyprotein directly from the FMDV IRES
(plus 2A-3D) significantly recovered replication of the 3D-GNN
replication-defective replicon, demonstrating an approximately
100-fold increase in ptGFP expression. In contrast, no recovery
was observed when expressing 3D alone (plus 3D), compared to
the yeast tRNA control (Fig. 8B). Thus, it appears that recovery of
3D mutations requires at least one 3D-containing higher-order
precursor.
DISCUSSION
The ability of some components of picornaviral replication to
be supplied in trans has been well documented, including the
NS proteins 2B, 3A, and 3D and RNA elements such as the CRE
and the IRES (36, 39, 40, 54–57, 99, 100). However, it has not
always been clear why certain protein or RNA functions can be
successfully supplied in trans while others cannot. We have
recently reported the use of random transposon-mediated mu-
tagenesis of an FMDV replicon to identify sites across the NS
polyprotein at which the insertion of foreign sequences abro-
gates replication (56). In the same report we demonstrated that
replication of such replication-defective insertion mutants in
the 3A protein could be recovered by cotransfection with a
wild-type helper replicon.
cis and trans Activities of 3D in FMDV Replication
August 2016 Volume 90 Number 15 jvi.asm.org 6875Journal of Virology
 o
n
 Septem
ber 6, 2016 by UNIVERSITY O
F LEEDS
http://jvi.asm.org/
D
ow
nloaded from
 
FIG 6 Replication-defective mutations to the 5= UTR improve recovery of 3D mutations. (A) Schematic of the mutant ptGFP FMDV replicon genome and a
simplified version of the mCherry genomes used in the reciprocal complementation assay. BHK-21 cells seeded into 24-well plates were cotransfected with
replication-defective 3Dmutant ptGFP replicons or wild-type control, together withmCherry replicons containing either an entire S-fragment deletion (S) (B
and D) or a replication-defective CRE mutation (CREA1G) (C and E). Wild-type mCherry helper replicon and yeast tRNA cotransfections were included as
controls. Expression of ptGFP (B and C) and mCherry (D and E) was monitored hourly over a 24-h period. Data represent mean positive cells per well SD at
8 h posttransfection. Significance of differences between treatment and yeast tRNA negative control (n 2): *, P 0.05; **, P 0.01; ***, P 0.001.
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FIG 7 Structure of the 3D-GC216/7AA mutant polymerase in complex with RNA. (A) Front view of a ribbon diagram of the 3D protein (gray) with the
substituted amino acids A216 and A217 shown as light blue spheres. The seven conserved structure-sequence motifs are colored as follows: A, red; B, green; C,
yellow; D, light blue; E, orange; F, blue; G, pink. (B) Electron density map around residues A216 and A217. Stereoview of a weighted 2Fo-Fc Fourier map,
contoured at 1.5 , with the model placed inside (sticks colored in atom type code). (C) Superimposition of the wild-type (orange) and mutant (gray) 3D RNA
structures. The regions showing the largest variations are highlighted as close-up insets: themutated loop (left panel) and the entry of the template channel (right
panel).
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In this study, we have extended these observations to inves-
tigate replication-defective insertion sites in the viral RdRp
gene encoding 3D. In cotransfection complementation exper-
iments, approximately one-half of the replication-defective in-
sertion mutants were significantly recovered in trans by a wild-
type helper replicon. The insertions in these recoverable
mutants were located within catalytic motifs of the polymerase,
in particular, motifs A, C, and F. In contrast, insertions in
nonrecoverable mutants were located within regions hypothe-
sized to be responsible for protein-protein and/or protein-
RNA interactions. Using this information, we designed specific
point mutations within the polymerase catalytic domain motif
A, which were also significantly recovered in trans using a wild-
type replicon, and within the putative dsRNA exit site, which
were not recoverable with wild-type helper replicon. Such mu-
tations did not detectably alter the processing or cellular local-
ization of 3D. However, structural studies implicated altered
RNA binding affinity as being responsible for the biochemical
lesion in the 3D protein bearing mutations at the RNA exit site.
None of the 3D mutations tested here showed dominant neg-
ative effects on the replication of any helper construct. To-
gether, our data imply a novel nonenzymatic, cis-acting role of
3D in FMDV replication, which is distinct from the polymer-
ization functions, which can be efficiently supplied in trans. We
hypothesized that 3D interacts in a cis-preferential manner
with structured elements within the 5= UTR and that removal
of such elements from the helper replicon would aid recovery
of replication-defective 3D mutations by increasing the avail-
ability of 3D to function in trans. In accordance with this hy-
pothesis, removal of 5=-UTR RNA elements allowed for recov-
ery of cis-acting 3D mutations.
Models for picornavirus genome replication derived from
work with PV require a noncovalent interaction between the 5=
and 3= UTRs involving host cell and viral proteins in a ribonu-
cleoprotein complex to facilitate efficient translation and/or
replication (37, 58, 59, 64, 65, 68–73). The 5= end of the PV
genome appears to be required in cis for efficient 3D-mediated
VPg uridylylation, a process that is stimulated in the presence
of 3C or particularly 3CD (37, 49, 52, 53). In addition, it has
been observed that 3CD and 3C bind to elements within the 5=
UTRs of PV and FMDV, respectively (59, 66). Biochemically,
3D has been shown to possess no polymerase activity in its
precursor form(s), suggesting that processing of 3D from its
precursor is required in the replication complex to facilitate
VPg uridylylation and genome replication (60–62). Combining
these observation with the findings presented in this study, it is
tempting to speculate that 3D either alone or as part of a larger
precursor, such as P3, binds preferentially in cis to the positive-
FIG 8 Expression of 3D alone is not sufficient for recovery of 3D mutations. (A) Western blot analysis of helper construct DNA transfected into BSR-T7 cells.
Cells were seeded into 12-well plates, allowed to adhere for 16 h, and transfectedwithDNAconstructs as indicated; proteinwas harvested at 12 h posttransfection.
Lysates were analyzed by Western blotting for 3D and GAPDH expression. (B) For reciprocal complementation, BHK-21 cells seeded into 24-well plates were
cotransfectedwith ptGFP replicons bearing the 3D-GNNreplication-defectivemutation orwild-type control, togetherwithRNA transcripts expressing 3D alone
or the entire 2A-3D polyprotein. Cotransfections were also performedwith wild-typemCherry ormCherry-S replicon transcripts and the equivalent 3D-GNN
mutant constructs. Expression of ptGFP was monitored hourly over a 24-h period. Data represent mean positive cells per well  SD at 8 h posttransfection.
Significance compared to yeast tRNA control (n 3): *, P 0.05; **, P 0.01; ***, P 0.001.
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sense RNA to help form the viral ribonucleoprotein complex
and facilitate the transition from a translational to a replicating
form. Subsequent recruitment of additional molecules of 3D
that are readily supplied in trans would allow uridylylation of
VPg and replication of the genome (Fig. 9). Such a model
would support the idea of the involvement of differential 3D
protein-protein interactions and higher-order 3D multimers
as suggested by genetic and structural data and by recent work
on PV in cell-free systems (74–79). Similar genetic comple-
mentation studies with other positive-sense RNA viruses such
FIG 9 Model of the cis and trans functions of 3D. 3D, either alone or as part of a larger precursor, interacts in cis with structural element within the 5= UTR. In
contrast, the polymerase functions of 3D can be readily supplied in trans. Cellular proteins are recruited at both the 5= and 3= UTRs. In addition, 5=-3= RNA
interactions are likely to be involved in the formation of an essential ribonucleoprotein complex.
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as hepatitis C virus (HCV) have identified essential cis-acting
functions of viral nonstructural proteins, including the HCV
RdRpNS5B (101). Recent work by Kazakov et al. demonstrated
that althoughNS5B polymerization activities could be supplied
in trans, expression was also required in cis, indicative of a
cis-acting role in replication complex assembly, distinct from
the enzymatic activity. Such observations are consistent with
the findings presented in this study and could imply a similar
cis-acting role of RNA polymerases across all positive-sense
RNA viruses (101).
The data presented here suggest that recovery of replica-
tion-defective mutations occurs through mixing of replication
complexes and not through nonreplicative (i.e., homologous)
recombination. The majority of replication-defective genomes
amplified by reverse transcription-PCR still maintained the
mutagenic insertion. However, a small number of recombinant
genomes were detected, presumably as a result of polymerase
strand switching during RNA replication. This finding, to-
gether with our other observations, suggests that recovery oc-
curs through the mixing of replication complexes or sharing of
viral NS proteins, and it is therefore likely that genome recom-
bination in our system is a downstream process following from
successful complementation. Despite the generally good levels
of recovery observed with 3D motif A and motif C mutations,
ptGFP expression never achieved the levels observed with the
wild-type construct. However, it is important to keep in mind
that recovery of replication-defective 3D mutations relies on
simultaneous cotransfection of the replication-defective con-
struct with the helper construct. Therefore, the imperfect re-
covery observed in our system is likely to be largely limited by
the intrinsic efficiency of RNA cotransfection, although other
possibilities, such as the efficiency of delivering 3D molecules
in trans between replication complexes, could also play a role.
Further studies employing infectious virus as a helper in com-
plementation experiments are therefore warranted to differen-
tiate between these two possibilities.
Of note, our initial insertional mutagenic screening (Fig. 2)
also identified replication-defective nonrescuable insertions in
the regions predicted to form putative protein-protein interac-
tions (3DTn-I102, 3DTn-C249, and 3DTn-S250). Such obser-
vations would be consistent with both our data and previous
models, whereby 3D/3CD protein-protein interactions and
higher-order 3D multimers are proposed to be essential for
ribonucleoprotein and replication complex formation (58, 59,
65, 75–79, 102). Further studies are ongoing to investigate the
cis versus trans viral and host cell protein-protein interactions
generated in the formation of the replication complex and how
3D/3CD molecular protein interactions contribute in cis as
part of a ribonucleoprotein complex and the transition from
translation to genome replication.
In summary, we have identified novel cis and trans functions
of the FMDV 3D RNA-dependent RNA polymerase that are
essential for viral RNA replication. This includes a previously
undescribed nonenzymatic cis-preferential role of 3D, which
our data imply has altered RNA binding affinity and plays a role
in binding structured RNA elements in the UTR. Our data
advance the current understanding of picornavirus replication
complex assembly.
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